It is over-expressed in many fibrotic disorders including scleroderma, kidney and liver fibrosis [19]–[21], [12] and constitutive expression of CCN2/CTGF in tissues is considered to indicative for pathological lesions [5]. The gene discussed is CCN2; the disease is scleroderma.